Back to Results
First PageMeta Content
Endocrine system / Peptide hormones / Dipeptidyl peptidase-4 inhibitors / Amides / Diabetes / Liraglutide / European Medicines Agency / Incretin / Glucagon-like peptide-1 / Anti-diabetic drugs / Chemistry / Medicine


GLP1 based therapies_13-03-26_PR
Add to Reading List

Document Date: 2013-07-21 06:41:00

Open Document

File Size: 89,64 KB

Share Result on Facebook

City

London / /

Company

Press Office Press / /

Country

United Kingdom / /

/

Facility

Canary Wharf / /

IndustryTerm

Healthcare professionals / food / /

MedicalCondition

diabetes mellitus / pancreatitis / inflammation / drug-induced pancreatitis / diabetes / /

Organization

Committee for Medicinal Products for Human Use / European Union / European Medicines Agency / American Diabetes Association / E-mail press@ema.europa.eu Website www.ema.europa.eu An / Pharmacovigilance Risk Assessment Committee / European Commission / /

Person

Monika Benstetter / Martin Harvey / /

/

Product

Janumet / Byetta / Januvia / glucagon / /

URL

www.ema.europa.eu / http /

SocialTag